Related Experiment Video
Updated: Jun 7, 2025

A Quantitative Glycomics and Proteomics Combined Purification Strategy
Published on: March 8, 2016
High-throughput glycosaminoglycan extraction and UHPLC-MS/MS quantification in human biofluids.
Nicola Volpi1, Fabio Galeotti2, Francesco Gatto3
1Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy. nicola.volpi@unimore.it.
A new method accurately quantifies glycosaminoglycans (GAGs) in biofluids using UHPLC-MS/MS. This high-throughput technique simplifies analysis for clinical labs, enabling biomarker discovery.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Biomedical Science
Background:
- Glycosaminoglycans (GAGs) are crucial heteropolysaccharides with complex structures dictating biological functions.
- Accurate, high-throughput quantification of GAGs in biofluids is vital for biomedical research and diagnostics.
- Current GAG quantification methods are often hindered by complex sample preparation, low throughput, and insufficient accuracy due to structural variability.
Purpose of the Study:
- To develop and validate a streamlined, high-throughput method for extracting and quantifying diverse GAGs in biofluids.
- To enable precise measurement of 17 disaccharides from major GAG classes, including chondroitin sulfate, heparan sulfate, and hyaluronic acid.
- To provide a scalable and reproducible protocol suitable for clinical laboratory settings.
Main Methods:
- Enzymatic depolymerization of GAGs from biofluid samples.
- Derivatization of released GAGs using 2-aminoacridone for enhanced detection.
- Quantification via ultra-high-performance liquid chromatography coupled with triple-quadrupole mass spectrometry (UHPLC-MS/MS) on a 96-well plate format.
Main Results:
- The developed UHPLC-MS/MS method allows for the simultaneous quantification of 17 GAG-derived disaccharides.
- The protocol is designed for 96-well plates, processing up to 82 samples per run with high precision and reproducibility.
- Sample preparation to MS analysis completion takes approximately 1.5 days, plus 15 minutes of MS runtime per sample, fitting standard working hours.
Conclusions:
- This UHPLC-MS/MS protocol offers a robust, scalable, and accurate solution for high-throughput GAG analysis in biofluids.
- The method's efficiency and precision make it a valuable tool for clinical laboratories aiming to utilize GAGs as biomarkers.
- The streamlined workflow overcomes limitations of existing methods, facilitating broader application in biomedical research and diagnostics.
More Related Videos
10:59Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
14:02Glycoproteomics of the Extracellular Matrix: A Method for Intact Glycopeptide Analysis Using Mass Spectrometry
Published on: April 21, 2017